Sapna for leprosy

Reading File

Finding Sources

Searching the Web

Sapna leprosy drug or treatment

"Sapna" is not a drug or treatment - it's an IEC (Information, Education, Communication) mascot/awareness concept used by India's National Leprosy Eradication Programme (NLEP).

What it is: "Sapna" is designed as a common girl living in the community (can be depicted as a local schoolgoing girl) who helps spread awareness about leprosy through key messages. There can be multiple "Sapna" figures across different villages - it's a flexible, relatable mascot rather than a single fixed character.
Purpose: It supports NLEP's community outreach goals, particularly the 2025-26 theme: "Together, let us raise awareness, dispel misconceptions and ensure that no one affected by leprosy is left behind." The mascot is used to combat stigma, encourage early self-reporting of symptoms, and promote treatment adherence.
Fits within broader NLEP strategy, which includes:
- Free Multi-Drug Therapy (MDT) - rifampicin, dapsone, and clofazimine - for all patients at public health facilities (India moved to a uniform 3-drug regimen for both paucibacillary and multibacillary leprosy nationwide from April 1, 2025).
- Post-exposure prophylaxis (PEP) with single-dose rifampicin (SDR) for eligible household/close contacts of index cases to interrupt transmission.
- Active case detection and timely referral/follow-up to ensure treatment completion.

If you meant something different by "Sapna" (e.g., a specific drug, a person's case, or a program in another country), let me know and I can look further. If you actually wanted the clinical treatment regimen for leprosy itself (WHO MDT protocol, dosing, duration for PB vs MB disease, or management of lepra reactions), I can pull that from the medical textbooks in detail.

This is a shared conversation. Sign in to Orris to start your own chat.